Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trialYoung‐Suk Lim, Seungbong Han, Jonggi Choi et al.|The Lancet. Gastroenterology & hepatology|2025Cited by 23